University ofKansas Cancer Center

Site:	University ofKansas Cancer Center
Address:	4001 Rainbow Blvd.
City:	Kansas City
State:	KS
Zip:	66160
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug	NCT#
3	(Peak) A Phase 3 Randomized Trial of CGT9486+Sunitinib vs. Sunitinib in Subjects With Gastrointestinal Stromal Tumors	Recruiting	Active, not recruiting	Bezuclastinib plus Sunitinib	NCT05208047